知镜 Cognispect · 医学文献与研究工作台

Beyond Euthyroid Sick Syndrome: Pre-Admission Levothyroxine Use and Thyroid Hormone-Outcome Associations in Hospitalized Patients.

Sheikh-Ahmad M, Rosenblatt I, Rabani H, Henig C, Dakwar B, Yovanovich E, Khoury E, Saiegh L.
Journal of clinical medicine · 2026-10-28 · PMID 43030527

文献摘要

Background/Objectives: Pre-admission levothyroxine use may influence the interpretation of thyroid tests beyond the conventional framework of non-thyroidal illness syndrome (NTIS). We examined whether thyroid hormone-outcome associations differed by treatment status. Methods: This retrospective study included medical inpatients with thyroid-stimulating hormone (TSH) Results: Among 14,332 matched patients, 3717 had complete data (1986 users; 1731 nonusers). Higher free triiodothyronine (FT3) in nonusers was associated with shorter hospitalization (incidence-rate ratio [IRR] 0.76, 95% confidence interval [CI] 0.73-0.80) and lower mortality odds (odds ratio [OR] 0.47, 95% CI 0.35-0.62). Free thyroxine (FT4) associations differed by levothyroxine use for both hospitalization length (interaction IRR 0.95, 95% CI 0.94-0.97) and mortality (interaction OR 0.83, 95% CI 0.77-0.90; both p Conclusions: FT4-outcome associations differed by pre-admission levothyroxine use, extending the established low-T3 prognostic framework to treatment-specific hormone patterns. These findings support considering treatment history when interpreting inpatient thyroid tests. Selective testing and residual confounding limit causal interpretation.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。